The control of Newcastle disease in England and Wales has been based on the voluntary use of inactivated vaccine since the acceptance in 1962 of the report of a Departmental Committee on Fowl Pest. At that time the poultry population was approximately 90 million, there was an annual production of 150 million broilers, 80% of the poultry population was kept intensively and disease was widespread. It is in the light of this background that the following observations are made.
Production ofa Potent Vaccine
The causal agent of Newcastle disease is a myxovirus; while several strains of virus have been isolated no antigenic differences have been demonstrated in any found in this country and there is no conclusive evidence of this elsewhere.
An inactivated vaccine which will produce a satisfactory immunity can be made from any of the lentogenic or mesogenic strains found in this country as was shown by Simmins & Baldwin (1963) ; the strains most commonly used at present are the Herts 1933 strain or a similar velogenic strain of imported origin. When using these strains it is important that they should be adequately inactivated, the agent favoured being either P-propiolactone or formalin.
The manufacture for sale or the importation of veterinary vaccine is controlled by licence. A standard of potency, i.e. that each vaccinating dose should contain 50 PD50, was laid down for Newcastle disease vaccine as well as details of production and tests for quality and purity. One important requirement of the potency test is that the challenge strain of virus must always be a specific strain known as the Weybridge Herts 1933 strain.
Availability and Distribution of Vaccines
When the change to a vaccination policy was announced in 1962 a limited supply of vaccine was available. Production was quickly increased and imports made when, to encourage its use, the Ministry decided to subsidize vaccine sales for a period of two years.
Subsidized Vaccines
Subsidized vaccines, available at id per dose, were distributed throughout the country from local offices of the Ministry. Refrigeration facilities were installed at distribution points and bulk supplies were held regionally in local cold stores. A huge propaganda campaign was mounted to encourage its sale and use. This covered several points. It was intended that the owners themselves should perform the vaccination and as a result few or no vaccinations were done by veterinary surgeons. Initially, the Ministry's veterinary service had the task of instructing a vast number of laymen in the technique of vaccination and instructional films were produced by the Ministry and one manufacturer.
Vaccination Teams
The necessity of vaccinating large numbers of birds proved beyond the capacity of many owners. As a result vaccinating teams were formed by poultry organizations and specialist firms. The members of these were lay people allowed to vaccinate by legal authority and trained to follow a routine technique and to observe disease precautions. To equip these teams special multidose syringes were manufactured.
Vaccination Programme
In Newcastle disease the young chick is most susceptible and with many thousands at risk it is. necessary to protect them as soon as possible. However, the timing of this vaccination is governed by the amount of maternal antibody present and this I think is the most important single factor affecting the use and efficacy of vaccine.
The maternal antibody content of the chick is dependent on the vaccinal status of the parent flock or the flock's exposure to infection. Keeble & Wade (1963) proved that chicks from an unvaccinated or once vaccinated parent are capable of an adequate serological response when vaccinated at 10 days but in the case of chicks originating from a twice vaccinated parent the interval should be twenty-one days. It was therefore agreed that the first injection be given at 3 weeks of age. In certain cases where there was a high degree of risk vaccination was carried out at 10-14 days and repeated fourteen days later; however, with the passage of time the need for this double vaccination has ceased.
It was found from experience that to obtain a full level of protection in areas of heavy infection a triple vaccination programme should be carried out, namely at 21 days, 8-10 weeks and 16-20 weeks of age.
This programme is now advocated by most vaccine manufacturers and, if followed, gives satisfactory protection. Cases, however, do occur in allegedly vaccinated birds which on investigation prove to be vaccination failures.
Vaccination Failures
The chief causes of these are:
(1) Insufficient vaccination coverage: It was originally considered that a coverage of between 80 and 85 % was necessary for reasonable disease control, but the latter figure was in fact never achieved; 75 % coverage has produced satisfactory results and the aim has been to maintain this level. Table 1 shows that vaccine had been in use for two years before there was any appreciable effect on the incidence of disease.
The cost of vaccination is a very important item in the profitability of the poultry industry. There is a natural tendency when disease incidence is low for the use of vaccine in the area to decline. This has resulted in a build up of infection and flocks with waning immunity showing clinical disease. This is a situation which has to be guarded against by repeated reminders of the benefits of vaccination.
(2) Inefficient storage of vaccine: This can occur after vaccine has reached the poultry farmer and in some of the investigated cases vaccine had been kept in what amounted to practically hot-house conditions. In 1946, when all the military forces from overseas were returning home, this country experienced the greatest increase in paralytic poliomyelitis it had ever known. The incidence remained high until vaccination got the better of it and reduced the number of paralytic cases to fewer than 10 per year. The disease left many of its victims alive but paralysed and thus there was a high emotional force driving the virologists to find the best vaccine and vaccination schedule to eliminate it. After the development of a successful vaccine in America the Medical Research Council had no difficulties in obtaining volunteers to test British-
